JERUSALEM , Feb. 19, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies in tablet form, ...
Please provide your email address to receive an email when new articles are posted on . A new Fracture Risk Assessment Tool includes information from high-resolution peripheral quantitative CT scans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results